Company Active LTD

Company profile

Arete Medical Technologies Ltd

ERROR: The requested URL could not be retrieved

Arete Medical Technologies Ltd is a UK company with status active founded in 2017 based in East of England.

CRN
10855152
Founded
2017
Age
8

Overview

Legal name
ARETE MEDICAL TECHNOLOGIES LTD
Region
East of England
Registered address
FUTURE BUSINESS CENTRE
KINGS HEDGES ROAD
CAMBRIDGE
UNITED KINGDOM
CB4 2HY
Insolvency history
No

Latest accounts

Financial period: 1 Aug 2024 to 31 Jul 2025

FULLACCOUNTS
Turnover
Unknown
Profit / Loss
Unknown
Employees
3

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Apr
2027

Accounts due

Accounts Due

Next accounts due date

20 Jul
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Jul
2025

Accounts filed

Accounts

Last accounts made up date

06 Jul
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

07 Jul
2017

Incorporated

Inception

Company registered at Companies House

Public funding

7 awards
First funded
2018
Funded years
2018, 2020, 2021, 2022
Age at first award
0 years

Projects

2022 Collaborative R&D Lead participant

Specialist-grade lung measurements to home use for chronic lung conditions: design for manufacture and clinical feasibility

1 Oct 2022 to 31 Mar 2024

Awarded
£265,441
Total cost £379,202

This is a project led by AMT, with co-applicant partner of CLCH NHS Trust, and with manufacturing SME sub-contractors. The solution tackles the major challenges associated with Chronic Respiratory Diseases (CRD's). The project heavily involves stakeholders within the NHS and user inputs and aims to develop the Respicorder from an in-clinic prototype towar...

2021 Collaborative R&D Lead participant

Respiratory Measurement Product Resilience Fund

1 Dec 2021 to 31 Jan 2022

Awarded
£55,000
Total cost £55,000

The base project is a Eureka Eurostars project, collaborating with an SME and university hospital in the Netherlands. Chronic respiratory diseases are a major cause of death, suffering, and healthcare costs. The core problems are: 1) the state of the condition can change daily and 2) the conditions are highly heterogeneous, with variability in inflammatio...

2020 Feasibility Studies Lead participant

Continuity for RESPICORDER projects developing a personal lung monitoring device and digital health platform

1 Jun 2020 to 31 Mar 2021

Awarded
£110,735
Total cost £110,735

no public description

2020 EU-Funded Lead participant

RUBICORD

1 May 2020 to 30 Apr 2023

Awarded
£312,474
Total cost £520,790

Awaiting Public Project Summary

2020 Study Lead participant

Respicorder device development

1 May 2020 to 30 Jun 2021

Awarded
£130,719
Total cost £186,742

Chronic respiratory diseases like asthma and chronic obstructive pulmonary disease (COPD) cause a significant burden to those affected and health system expenditure. There is a great need for new and wider deployment of diagnostics, well recognised by patient charity groups, clinician societies, and healthcare evidence appraisers. This could help identify...

2018 Feasibility Studies Lead participant

Business Feasibility and Strategy for Precision Respiratory Diagnostic Device

1 Mar 2018 to 28 Feb 2019

Awarded
£68,236
Total cost £97,480

"This feasibility study project is to understand and develop business strategies for an innovative diagnostic device for chronic respiratory diseases, such as asthma and COPD. We are developing our device to help doctors make precision medicine decisions. This will help people with respiratory diseases find effective treatments faster and more accurately....

2018 Feasibility Studies Lead participant

Algorithm Development for Respiratory Diagnostic Device

1 Feb 2018 to 31 Mar 2019

Awarded
£52,285
Total cost £74,693

This feasibility study project is to develop and evaluate concepts for software-based methods that improve respiratory diagnostic devices. Improvements are expected to the overall cost, usability, and access for the device. With a software-driven approach, personalised medicine approaches to diseases like asthma and COPD become possible. By helping to per...

Product types

Collaborative R&D EU-Funded Feasibility Studies Study